KMKoutarou Maeda

Koutarou Maeda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Koutarou Maeda has a total of 169 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prognostic Power of Ensemble Learning in Colorectal Cancer with Peritoneal Metastasis: A Multi-Institutional Analysis

    by Yoshiko Bamba, Michio Itabashi, Hirotoshi Kobayashi, Kenjiro Kotake, Masayasu Kawasaki, Yukihide Kanemitsu, Yusuke Kinugasa, Hideki Ueno, Kotaro Maeda, Takeshi Suto, et al.

    Background: Owing to significant clinical heterogeneity, the achievement of accurate survival forecasting for individuals with colorectal cancer and peritoneal metastasis continues to be a complex undertaking. We aimed to transcend traditional prognostic limitations by evaluating machine learning boosting models against standard regression-based methods in terms of estimating overall survival (OS). Methods: Utilizing a multi-institutional registry of 150 patients diagnosed with synchronous peritoneal metastasis of colorectal cancer, we integrated 124 clinicopathological variables to refine our predictive models. Beyond standard preprocessing—including standardization and median imputation—we rigorously compared XGBoost and LightGBM against Ridge, Lasso, and linear regression via five-fold cross-validation. To specifically address right-censoring, an XGBoost Cox model was implemented and validated using Harrell’s C-index, with SHAP and LIME providing essential model interpretability. Results: Boosting models consistently outperformed linear alternatives, which struggled with high error rates and negative R2 values. Specifically, XGBoost achieved an MAE of 475 ± 60 and an RMSE of 585 ± 88. The XGBoost Cox model reached a C-index of 0.64 ± 0.06. SHAP analysis highlighted inflammatory markers and peritoneal disease extent as the most influential prognostic drivers. Conclusions: While boosting models offer a clear accuracy advantage over linear methods, their prognostic power remains moderate. These findings underscore the potential of ensemble learning in oncology, yet mandate external validation before these tools can be integrated into clinical decision-making.

  • Open Access

    Machine Learning-Based Survival Time Prediction in Colorectal Cancer with Peritoneal Metastasis: A Multi-Institutional Registry-Based Study

    by Yoshiko Bamba, Michio Itabashi, Hirotoshi Kobayashi, Kenjiro Kotake, Masayasu Kawasaki, Yukihide Kanemitsu, Yusuke Kinurgasa, Hideki Ueno, Kotaro Maeda, Takeshi Suto, et al.

    Background: Prognostic prediction for colorectal cancer patients with peritoneal metastasis remains challenging due to clinical and biological heterogeneity. We aimed to evaluate the utility of machine learning, comparing high-performance boosting models with interpretable regression approaches for overall survival (OS) prediction. Methods: We analyzed a multi-institutional registry cohort of 150 colorectal cancer patients with synchronous peritoneal metastases. A total of 124 variables were included; continuous variables were standardized, categorical variables were one-hot encoded, and missing values were imputed using the median. Models included XGBoost, LightGBM, Ridge regression, Lasso regression, and linear regression. Training was performed with 3-fold cross-validation, and hyperparameters were optimized using Optuna. Evaluation metrics included mean absolute error (MAE), root mean square error (RMSE), and coefficient of determination (R²). Model interpretability was assessed using SHAP values, LIME local explanations, and regression coefficients. Results: Boosting models consistently outperformed linear models. XGBoost achieved the best performance (MAE 424, RMSE 526, R² = 0.04), while LightGBM showed comparable accuracy. In contrast, Ridge, Lasso, and Linear regression yielded high errors (MAE > 900, RMSE > 1200) with negative R² values, indicating poor predictive ability. SHAP analysis highlighted systemic inflammation markers (CRP, BUN), surgical assessment of tumor depth, operative factors (time, bleeding), and peritoneal metastasis characteristics as major determinants of OS. LIME analyses further provided case-specific interpretability, identifying feature contributions in long-, intermediate-, and short-term survivors. Conclusion: Boosting models, particularly XGBoost, demonstrated superior performance compared with traditional regression models in predicting OS for colorectal cancer patients with peritoneal metastasis, although absolute predictive accuracy remains modest. Integration of SHAP and LIME linked model outputs with clinically plausible prognostic factors, enhancing interpretability. Ensemble learning may provide a promising adjunct for prognostic assessment and should be validated in larger, genomically enriched cohorts.

  • Open Access

    Pharmacotherapy for fecal incontinence: potential treatment with a traditional Japanese medicine Kampo

    by Kotaro Maeda, Toshinobu Sasaki, Tomohisa Hattori

    Fecal incontinence (FI) significantly impairs patient quality of life and creates substantial distress not only for affected individuals but also for nurses and caregivers. The prevalence of FI among older adults is estimated at up to 20%, although the sensitive nature of the condition often prevents active reporting by patients. This article reviews risk factors and pharmacotherapies for FI, emphasizing the therapeutic potential of Daikenchuto (DKT). The etiology of FI is multifactorial and lacks a singular definition. Currently, no prescription drugs specifically approved for FI are available, leaving treatment options limited. Nonetheless, major clinical guidelines have identified several viable pharmacological approaches. Strongly recommended treatments include the antidiarrheal agent loperamide and stool bulking or solidifying agents, such as dietary fiber and polycarbophil. Other therapeutic options include ramosetron, a 5-HT3 receptor antagonist; amitriptyline, a tricyclic antidepressant; and sodium valproate and diazepam, which are GABAergic neuromodulators. Recently, research has explored the efficacy and mechanism of action of DKT, a traditional Japanese medicine Kampo. Historically used for abdominal symptoms like bloating and known for promoting intestinal motility, emerging evidence suggests DKT may also effectively manage FI.

  • Open Access

    An Exploratory Study on the Contractile Effects of Hydroxy-α-Sanshool and Hydroxy-β-Sanshool, the Active Ingredients of Daikenchuto, on the Internal Anal Sphincter

    by Kotaro Maeda, Toshinobu Sasaki

    Objectives: Daikenchuto (DKT) enhances the contraction of the internal anal sphincter (IAS) in patients with constipation and fecal incontinence; however, the mechanism of its action is unknown. We investigated the effects of the active ingredients of DKT (hydroxy-α-sanshool (HAS) and hydroxy-β-sanshool (HBS)) on the contractile activity of the canine rectum and IAS. Methods: Three male beagle dogs were prepared for each of the HAS, HBS, and control groups. Force transducers were attached to the rectal and IAS surfaces of the dogs, and the contractile responses were measured by telemetry under conscious conditions. HAS (10 mg/body) and HBS (2.5 mg/body) were administered intrarectally at doses previously identified from an effective dose of DKT extract (1.5 g/body), and contractile responses were recorded up to 6 h after administration. Contractile activity of the rectum and IAS was evaluated by observing the area under the curve (AUC) of the recorded contraction waveform. Plasma concentrations of HAS and HBS were measured before and after administration to confirm IAS exposure to both ingredients. Results: The mean AUC values of the IAS for the control, HAS, and HBS groups at 10 min after administration were 115, 87, and 220 (g-min), respectively, indicating a higher contraction in the HBS group, which was maintained for approximately 3 h. As for the rectum, no contractile response was observed in either the HAS or HBS groups. Plasma concentrations of both ingredients peaked at 20 min after administration. Conclusions: HBS could be involved in the contractile action of DKT on the IAS.


  • Open Access

    Treatment of Rectovaginal Fistula

    by Kotaro Maeda, Norihito Wada, Atsuo Shida

    Rectovaginal fistula (RVF) is a challenging complication with unsatisfactory success and a significant burden for the patients. With insufficient clinical data due to the rare entity, the present state of treatments for RVFs was reviewed especially form the point of factors to determine management, classifications, principle of treatment, conservative and surgical treatments with outcomes. Size, fistula localization and etiology, type of fistula; "simple" or "complex," status of anal sphincter complex and surrounding tissue, presence or absence of inflammation, presence of diverting stoma, previous attempted repair and radiation therapy, patient's condition with co-morbidities, and surgeon's experience are important factors to determine the management of RVF. The inflammation should initially subside in cases with infection. Starting with conservative surgical options and interposing healthy tissue for complex or recurrent fistulas, invasive procedures will be performed if conservative treatment failed. Conservative treatment may be effective in RVFs with minimal symptoms and should be done for small RVFs for a 36 months usual period. Anal sphincter damage might need a repair of sphincter muscles along with RVF repair. Diverting stoma can initially be constructed in patients with severe symptoms and larger RVFs to relief the patient's pain. Simple fistula is usually indicated for local repair. Local repairs to transperineal and transabdominal approaches can be used for complex RVFs. Interposition of healthy, well-vascularized tissue can be required for more complex fistulas and abdominal procedures for high RVFs.


  • Open Access

    Prolapse of intestinal stoma

    by Kotaro Maeda

    Stoma prolapse can usually be managed conservatively by stoma care nurses. However, surgical management is considered when complications make traditional care difficult and/or stoma prolapse affects normal bowel function and induces incarceration. If the stoma functions as a fecal diversion, the prolapse is resolved by stoma reversal. Loop stoma prolapse reportedly occurs when increased intraabdominal pressure induces stoma prolapse by pushing the stoma up between the abdominal wall and the intestine, particularly in cases of redundant or mobile colon. Therefore, stoma prolapse repair aims to prevent or eliminate the space between the abdominal wall and the intestine, as well as the redundant or mobile intestine. Accordingly, surgical repair methods for stoma prolapse are classified into 3 types: methods to fix the intestine, methods to shorten the intestine, and methods to eliminate the space between the stoma and the abdominal wall around the stoma orifice. Additionally, the following surgical techniques at the time of stoma creation are reported to be effective in preventing stoma prolapse: an avoidance of excessive fascia incision, fixation of the stoma to the abdominal wall, an appropriate selection of the intestinal site for the stoma orifice to minimize the redundant intestine, and the use of an extraperitoneal route for stoma creation.


  • Open Access

    Long-term results of minimally invasive transanal surgery for rectal tumors in 249 consecutive patients

    by Kotaro Maeda, Yoshikazu Koide, Hidetoshi Katsuno, Yosuke Tajima, Tsunekazu Hanai, Koji Masumori, Hiroshi Matsuoka, Miho Shiota

    Purpose: To delineate the long-term results of minimally invasive transanal surgery (MITAS) for selected rectal tumors. Methods: We analyzed data, retrospectively, on consecutive patients who underwent MITAS between 1995 and 2015, to establish the feasibility, excision quality, and perioperative and oncological outcomes of this procedure. Results: MITAS was performed on 243 patients. The final histology included 142 cancers, 47 adenomas, and 52 neuroendocrine tumors (NET G1). A positive margin of 1.6% and 100% en bloc resection were achieved. The mean operative time was 27.4 min. Postoperative morbidity occurred in 7% of patients, with 0% mortality. The median follow-up was 100 months (up to ≥ 5 years or until death in 91.8% of patients). Recurrence developed in 2.9% of the patients. The 10-year overall survival rate was 100% for patients with NET G1 and 80.3% for those with cancer. The 5-year DFS was 100% for patients with Tis cancer, 90.6% for those with T1 cancer, and 87.5% for those with T2 or deeper cancers. MITAS for rectal tumors ≥ 3 cm resulted in perioperative and oncologic outcomes equivalent to those for tumors < 3 cm. Conclusion: MITAS is feasible for the local excision (LE) of selected rectal tumors, including tumors ≥ 3 cm. It reduces operative time and secures excision quality and long-term oncological outcomes.


  • Open Access

    Prevalence and Risk Factors of Anal and Fecal Incontinence in Japanese Medical Personnel

    by Kotaro Maeda, Yoshikazu Koide, Hidetoshi Katsuno, Tsunekazu Hanai, Koji Masumori, Hiroshi Matsuoka, Yosuke Tajima, Tomoyoshi Endo, Yeong Cheol Cheong

    Objectives: This study aimed to elucidate the actual state of anal incontinence (AI), fecal incontinence (FI), and the associated factors in Japanese medical personnel. Methods: A questionnaire was completed by Japanese medical personnel after listening to lectures on AI. AI was defined as involuntary loss of feces or flatus. Results: A total of 463 persons (mean age, 35.6 years; range, 20-91; male/female/no answer, 132/324/7) participated in the questionnaire. AI occurred in 34.4% of 450 participants (flatus/liquid stool/solid stool: 30.4%/3.6%/0.4%). AI was significantly more prevalent in females (male/female: 15.5%/42.7%, p < 0.001). AI and FI occurred significantly more prevalent in participants aged ≥40 years (p < 0.024). AI was significantly associated with childbirth, frequency of childbirth (more than three times), vaginal delivery, urinary incontinence, the style of urination/defecation, and a history of gynecologic surgery and systemic diseases (p < 0.05). Female gender and age as well as urinary incontinence and inability to defecate separately in female and previous colorectal disease and/or surgery in male were risk factors of AI by multivariate analysis (p < 0.05). FI was correlated with urinary incontinence. Conclusions: AI and FI occurred in 34.4% and 4.0% of Japanese medical personnel, respectively. Gas incontinence was common in every age group. AI was associated with female gender, higher age group, urinary incontinence, the style of urination and defecation in female, and previous colorectal disease and/or surgery in male. FI was associated with urinary incontinence.


  • Open Access

    Questionnaire Survey of Bowel Habit in Japanese Medical Personnel

    by Kotaro Maeda, Yoshikazu Koide, Hidetoshi Katsuno, Tsunekazu Hanai, Koji Masumori, Hiroshi Matsuoka, Tomoyoshi Endo, Yeong Cheol Cheong

    Objectives: This study aims to clarify the bowel habit, change of bowel movement throughout the cycle of menstruation, and toilet use in Japanese medical personnel. Methods: A questionnaire survey was completed by Japanese medical personnel after listening to lectures on bowel disorders. Constipation was defined according to Rome III criteria, whereas diarrhea was defined as Bristol stool form scale type 6 and 7. Results: In total, 463 persons (mean age, 35.6 years, range 20-91, male/female/no answer: 132/324/7) have completed the questionnaire. Constipation was significantly more often observed in females (male/female: 3%/31%, p > 0.001, Chi-squared test), while diarrhea was noted to be less in females (male/female: 1%/7%). Constipation was observed in 20% of participants in their 20s, and the constipation rate was observed to gradually increase with age. It was observed in 45% of participants in their 70s or older. Bowel movement changed to constipation around menstruation in 18% of females and changed to diarrhea in 43% of females. Constipation often occurred before menstruation and diarrhea during menstruation. Only 2% of participants used a Japanese-style toilet, and 5% of participants claimed that they were unable to pass a stool on a Japanese-style toilet. Conclusions: Constipation was significantly more frequent in females and increased with age among female Japanese medical personnel. Change of bowel movement occurred in 61% of females around menstruation. Five percent of participants were unable to pass stools on a Japanese-style toilet.


  • Open Access

    Outcomes of Transvaginal Anterior Levatorplasty with Posterior Colporrhaphy for Symptomatic Rectocele

    by Kotaro Maeda, Katsuyuki Honda, Yoshikazu Koide, Hidetoshi Katsuno, Tsunekazu Hanai, Koji Masumori, Hiroshi Matsuoka, Tomoyoshi Endo, Yeong Cheol Cheong

    Objectives: To clarify the long-term outcomes of transvaginal anterior levatorplasty with posterior colporrhaphy for symptomatic rectocele with defecographic changes.Methods: Consecutive patients undergoing transvaginal anterior levatorplasty with posterior colporrhaphy for symptomatic rectocele were prospectively registered and retrospectively reviewed using medical records. Symptoms, fecal incontinence, and defecographic findings were evaluated before and after surgery.Results: Fifty-seven women (mean age, 68 years) were identified, and the median disease duration was 24 months. Symptoms of vaginal mass (n = 32) and difficult defecation (n = 21) disappeared (90.6% and 71.4%, respectively) or improved (6.3% and 28.6%, respectively) after surgery. However, the feeling of residual stool was unchanged in two of eight patients. Seventeen patients who performed digitation on defecation before surgery discontinued digitation after surgery. The proportion of patients who had fecal incontinence preoperatively (40.4%) decreased significantly after surgery (17.5%) during a median follow-up period of 47 months. Defecography revealed a disappearance or improvement of rectocele in all 18 patients examined. The average rectocele size decreased significantly in six improved patients (p = 0.0006, paired t-test).Conclusions: Transvaginal anterior levatorplasty with posterior colporrhaphy for symptomatic rectocele was a useful option to improve symptoms and anatomical disorders in the long term, but it had limitations in improving defecatory symptoms.